professor
Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany, Bayern, Germany
Prof. Dr. med. Leo Rasche attended medical school at the University of Würzburg, Germany, where he received his M.D. degree in 2009 with a focus on experimental pathology, followed by a residency in internal medicine and a fellowship in internal medicine and hematology/oncology. From 2016 to 2018, he was a postdoctoral fellow at the Myeloma Institute at the University of Arkansas for Medical Sciences in Little Rock, where he studied medical imaging, tumor genomics, tumor evolution, and immunotherapy approaches for the treatment of multiple myeloma. In 2018, he was appointed assistant professor of research at the University of Arkansas for Medical Sciences. In the summer of 2018, Dr. Rasche returned to Germany, where he is an attending physician at the myeloma service of the University Hospital of Würzburg. In 2022, he completed his habilitation in internal medicine, and in 2024, he was appointed full professor of clinical and translational myeloma research at the University of Würzburg.
Dr. Rasche has published over 100 articles in peer-reviewed journals such as Nature Medicine, Nature Communications, Nature Reviews Clinical Oncology, Blood, and Leukemia. He presented his findings at national and international conferences, and serves as reviewer for prominent journals, including the New England Journal of Medicine. In 2022, he was awarded the Artur-Pappenheim Preis, one of the highest awards by the German Society of Hematology and Oncology.
Dr. Rasche holds membership with several professional organizations, including the International Myeloma Working Group (IMWG) and International Myeloma Society (IMS).
Disclosure information not submitted.
Meet the Expert: How to manage 2L+ in the near future?
Thursday, September 26, 2024
7:00 AM – 8:00 AM East Coast USA Time
Saturday, September 28, 2024
10:00 AM – 11:00 AM East Coast USA Time